World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9699
World Ranking
4329
National Ranking
374

Nathan W. Bartlett publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nathan W. Bartlett sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 149 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nathan W. Bartlett D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nathan W. Bartlett sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nathan W. Bartlett is affiliated with Imperial College London in the United Kingdom. Their research contributions primarily lie within the field of Medicine, with a focus on infectious diseases, epidemiology, pulmonary and respiratory medicine, immunology, and physiology.

The scientist has a body of work that spans several interconnected topics, including:

  • Respiratory viral infections research
  • Asthma and respiratory diseases
  • SARS-CoV-2 and COVID-19 Research
  • IL-33, ST2, and ILC Pathways
  • Neonatal Respiratory Health Research
  • COVID-19 Clinical Research Studies
  • Pediatric health and respiratory diseases

Their frequent publication venues include:

  • American Journal of Physiology-Lung Cellular and Molecular Physiology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • EBioMedicine
  • American Journal of Respiratory Cell and Molecular Biology
  • European Respiratory Review

Some of their recently published papers include:

  • Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon, 2020, Journal of Allergy and Clinical Immunology
  • A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae, 2022, Science Translational Medicine
  • Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients, 2021, Frontiers in Immunology
  • Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD, 2020, Frontiers in Immunology
  • Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model, 2020, EBioMedicine

Bartlett has worked with several frequent co-authors, including:

  • Peter Wark
  • Camille Esneau
  • Kristy Nichol
  • Andrew T. Reid
  • Darryl A. Knight

Best Publications

  • Role of deficient type III interferon-λ production in asthma exacerbations

    Marco Contoli;Simon D Message;Vasile Laza-Stanca;Michael R Edwards

  • IL-33–Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo

    David J. Jackson;David J. Jackson;Heidi Makrinioti;Batika M. J. Rana;Betty W. H. Shamji

  • The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.

    Mary T. Harte;Ismar R. Haga;Geraldine Maloney;Pearl Gray

  • Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.

    Michael R. Edwards;Nathan W. Bartlett;Deborah Clarke;Mark Birrell

  • Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence

    Julianne Stack;Ismar R. Haga;Martina Schröder;Nathan W. Bartlett

  • Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation

    Nathan W Bartlett;Ross P Walton;Michael R Edwards;Juliya Aniscenko

  • Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation

    Janine Beale;Janine Beale;Janine Beale;Annabelle Jayaraman;Annabelle Jayaraman;Annabelle Jayaraman;David J. Jackson;Jonathan D. R. Macintyre

  • Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation

    Marie Toussaint;David J. Jackson;Dawid Swieboda;Anabel Guedan

  • Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium

    Louise Slater;Nathan Bartlett;Jennifer J. Haas;Jie Zhu

  • The microbiology of asthma

    Michael R. Edwards;Nathan W. Bartlett;Tracy Hussell;Peter Openshaw

  • Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein

    Samantha Cooray;Mohammad W. Bahar;Nicola G. A. Abrescia;Colin E. McVey

  • Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

    Aran Singanayagam;Nicholas Glanville;Jason L. Girkin;Yee Man Ching

  • The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity

    Adam Collison;Luke Hatchwell;Nicole Verrills;Peter A B Wark;Peter A B Wark

  • The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence.

    Nathan Bartlett;Nathan Bartlett;Julian A. Symons;David C. Tscharke;David C. Tscharke;Geoffrey L. Smith;Geoffrey L. Smith

  • Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

    Nathan W. Bartlett;Karen Buttigieg;Sergei V. Kotenko;Geoffrey L. Smith

  • A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13).

    Trevor T Hansel;Tanushree Tunstall;Maria-Belen Trujillo-Torralbo;Maria-Belen Trujillo-Torralbo;Betty Shamji

  • Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

    Peter M. George;Eduardo Oliver;Peter Dorfmuller;Olivier D. Dubois

  • Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.

    Lydia J. Finney;Nicholas Glanville;Hugo Farne;Julia Aniscenko

  • Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways.

    C.A. Hewson;J.J. Haas;N.W. Bartlett;S.D. Message

  • Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia

    Luke Hatchwell;Adam Collison;Jason Girkin;Kristy Parsons

  • Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

    Lydia J Finney;Nicholas Glanville;Hugo Farne;Julia Aniscenko

Frequent Co-Authors

Sebastian L. Johnston
Sebastian L. Johnston Imperial College London
Peter A. B. Wark
Peter A. B. Wark University of Newcastle Australia
Michael R. Edwards
Michael R. Edwards Imperial College London
Patrick Mallia
Patrick Mallia Imperial College London
Darryl A. Knight
Darryl A. Knight University of Newcastle Australia
Joerg Mattes
Joerg Mattes University of Newcastle Australia
Geoffrey L. Smith
Geoffrey L. Smith University of Oxford
Paul S. Foster
Paul S. Foster Woolcock Institute of Medical Research
Alberto Papi
Alberto Papi University of Ferrara
Maria G. Belvisi
Maria G. Belvisi Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various specialized healthcare careers. Many students interested in bridging clinical practice with immunological expertise often explore nursing pathways. For those beginning their nursing journey, programs like easiest absn programs to get into offer accelerated routes to becoming a registered nurse, ideal for those with a non-nursing bachelor’s degree.

Another foundational step is obtaining licenses through lpn programs easy to get into, which provide practical experience in patient care. Licensed Practical Nurses (LPNs) often work closely with immunology specialists, supporting patient treatments in clinics and hospitals.

For advanced clinical roles, easiest online nurse practitioner programs offer flexible and accessible options to become nurse practitioners (NPs). These programs enable professionals to deliver specialized care, including immunology-related treatments and research participation.

Specifically, individuals interested in mental health aspects intersecting with immunology might find value in top psychiatric mental health nurse practitioner programs online. These programs emphasize clinical placements and prepare graduates for critical roles in psychiatric care involving immunological factors.

Best Scientists Citing Nathan W. Bartlett

Trending Scientists

Recently Published Articles